Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1982 Apr;57(4):247–252. doi: 10.1136/adc.57.4.247

Retrolental fibroplasia--controlled study of 4 years' experience in a neonatal intensive care unit.

V Y Yu, D M Hookham, J R Nave
PMCID: PMC1627641  PMID: 6896273

Abstract

During the 4 years 1977-80, 14 infants developed retrolental fibroplasia (RLF) in the neonatal unit at this medical centre. All were very low birthweight (VLBW) infants who weighed 1500 g or less at birth. The incidence of RLF was 3.5% for all VLBW infants admitted for neonatal intensive care and 4.7% for VLBW survivors. The mean birthweight of the affected infants was 970 (range 730-1310) g and mean gestational age 26 (range 24-29) weeks. Seven of the affected infants (2.4% of VLBW survivors) had significant scarring with temporal dragging of the optic disc and retinal detachment. Each of the 14 infants was matched with 2 control infants in order to see whether any factors predisposing to the development of RLF, including those related to oxygen therapy and monitoring, could be identified. The only factor associated with RLF was a higher volume of blood given with replacement transfusions. The occurrence of RLF was unrelated to an increase in requirement for or duration of oxygen therapy, arterial oxygen tensions as determined by intermittent sampling, or the availability of transcutaneous oxygen monitoring. The care taken in oxygen therapy may have been responsible for failure to show a quantitative association between hyperoxaemia and RLF. Although the problem of oxygen therapy in preterm infants is far from being resolved, current neonatal intensive care methods have limited the occurrence of RLF to VLBW infants. This study demonstrated a lower incidence of RLF in VLBW infants despite an improved survival rate compared with that previously reported.

Full text

PDF
249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVERY M. E. Recent increase in mortality from hyaline membrane disease. J Pediatr. 1960 Oct;57:553–559. doi: 10.1016/s0022-3476(60)80083-2. [DOI] [PubMed] [Google Scholar]
  2. Adamkin D. H., Shott R. J., Cook L. N., Andrews B. F. Nonhyperoxic retrolental fibroplasia. Pediatrics. 1977 Dec;60(6):828–830. [PubMed] [Google Scholar]
  3. Addison D. J., Font R. L., Manschot W. A. Proliferative retinopathy in anencephalic babies. Am J Ophthalmol. 1972 Nov;74(5):967–976. doi: 10.1016/0002-9394(72)91220-2. [DOI] [PubMed] [Google Scholar]
  4. Aranda J. V., Sweet A. Y. Sustained hyperoxemia without cicatricial retrolental fibroplasia. Pediatrics. 1974 Oct;54(4):434–437. [PubMed] [Google Scholar]
  5. Bolton D. P., Cross K. W. Further observations on cost of preventing retrolental fibroplasia. Lancet. 1974 Mar 16;1(7855):445–448. doi: 10.1016/s0140-6736(74)92395-2. [DOI] [PubMed] [Google Scholar]
  6. CLASSIFICATION of retrolental fibroplasia. Am J Ophthalmol. 1953 Oct;36(10):1333–1335. [PubMed] [Google Scholar]
  7. Cross K. W. Cost of preventing retrolental fibroplasia? Lancet. 1973 Oct 27;2(7835):954–956. doi: 10.1016/s0140-6736(73)92610-x. [DOI] [PubMed] [Google Scholar]
  8. DANCIS J., LEWIS J. M., GUY L. P. Retrolental fibroplasia; a statistical study with particular reference to the effect of vitamin A. N Engl J Med. 1951 Sep 13;245(11):402–406. doi: 10.1056/NEJM195109132451103. [DOI] [PubMed] [Google Scholar]
  9. EXLINE A. L., Jr, HARRINGTON M. R. Retrolental fibroplasia; clinical statistics from the premature center of the Charity Hospital of Louisiana at New Orleans. J Pediatr. 1951 Jan;38(1):1–7. doi: 10.1016/s0022-3476(51)80079-9. [DOI] [PubMed] [Google Scholar]
  10. Faris B., Tolentino F. I., Freeman H. M., Brockhurst R. J., Schepens C. L. Retrolental fibroplasia in the cicatricial stage. Fundus and vitreous findings. Arch Ophthalmol. 1971 Jun;85(6):661–668. doi: 10.1001/archopht.1971.00990050663003. [DOI] [PubMed] [Google Scholar]
  11. Gunn T. R., Easdown J., Outerbridge E. W., Aranda J. V. Risk factors in retrolental fibroplasia. Pediatrics. 1980 Jun;65(6):1096–1100. [PubMed] [Google Scholar]
  12. KINSEY V. E. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol. 1956 Oct;56(4):481–543. [PubMed] [Google Scholar]
  13. Kalina R. E., Hodson W. A., Morgan B. C. Retrolental fibroplasia in a cyanotic infant. Pediatrics. 1972 Nov;50(5):765–768. [PubMed] [Google Scholar]
  14. Karlsberg R. C., Green W. R., Patz A. Congenital retrolental fibroplasia. Arch Ophthalmol. 1973 Feb;89(2):122–123. doi: 10.1001/archopht.1973.01000040124014. [DOI] [PubMed] [Google Scholar]
  15. Kingham J. D. Acute retrolental fibroplasia. Arch Ophthalmol. 1977 Jan;95(1):39–47. doi: 10.1001/archopht.1977.04450010041003. [DOI] [PubMed] [Google Scholar]
  16. Kinsey V. E., Arnold H. J., Kalina R. E., Stern L., Stahlman M., Odell G., Driscoll J. M., Jr, Elliott J. H., Payne J., Patz A. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics. 1977 Nov;60(5):655–668. [PubMed] [Google Scholar]
  17. Kraushar M. F., Harper R. G., Sia C. G. Rentrolental fibroplasia in a full-term infant. Am J Ophthalmol. 1975 Jul;80(1):106–108. doi: 10.1016/0002-9394(75)90879-x. [DOI] [PubMed] [Google Scholar]
  18. MALLEK H., SPOHN P. Retrolental fibroplasia. Can Med Assoc J. 1950 Dec;63(6):586–588. [PMC free article] [PubMed] [Google Scholar]
  19. MCDONALD A. D. CEREBRAL PALSY IN CHILDREN OF VERY LOW BIRTH WEIGHT. Arch Dis Child. 1963 Dec;38:579–588. doi: 10.1136/adc.38.202.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Obeyesekere H. I., Pankhurst S., Yu V. Y. Pharmacological closure of ductus arteriosus in preterm infants using indomethacin. Arch Dis Child. 1980 Apr;55(4):271–276. doi: 10.1136/adc.55.4.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Procianoy R. S., Garcia-Prats J. A., Hittner H. M., Adams J. M., Rudolph A. J. Use of indomethacin and its relationship to retinopathy of prematurity in very low birthweight infants. Arch Dis Child. 1980 May;55(5):362–364. doi: 10.1136/adc.55.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. RYAN H. Retrolental fibroplasia; a clinicopathologic study. Am J Ophthalmol. 1952 Mar;35(3):329–342. doi: 10.1016/0002-9394(52)90003-2. [DOI] [PubMed] [Google Scholar]
  23. Schrager G. O. PDAs, prostaglandins, and RLF. Pediatrics. 1978 Nov;62(5):860–861. [PubMed] [Google Scholar]
  24. Stefani F. H., Ehalt H. Non-oxygen induced retinitis proliferans and retinal detachment in full-term infants. Br J Ophthalmol. 1974 May;58(5):490–513. doi: 10.1136/bjo.58.5.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Svedbergh B., Lindstedt E. Retrolental fibroplasia in Sweden. General survey and selected study on patients born in 1960-1966. Acta Paediatr Scand. 1973 Sep;62(5):458–464. doi: 10.1111/j.1651-2227.1973.tb08138.x. [DOI] [PubMed] [Google Scholar]
  26. Yu V. Y., Hollingsworth E. Improving prognosis for infants weighing 1000 g or less at birth. Arch Dis Child. 1980 Jun;55(6):422–426. doi: 10.1136/adc.55.6.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yu V. Y., Hollingsworth E. Respiratory failure in infants weighing 1000 g or less at birth. Aust Paediatr J. 1979 Sep;15(3):152–159. doi: 10.1111/j.1440-1754.1979.tb01214.x. [DOI] [PubMed] [Google Scholar]
  28. Yu V. Y., James B., Hendry P., MacMahon R. A. Total parenteral nutrition in very low birthweight infants: a controlled trial. Arch Dis Child. 1979 Sep;54(9):653–661. doi: 10.1136/adc.54.9.653. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES